Kardigan (KARD) closed at $13.82 on November 13, 2026, down 2.1% from the previous close, on volume of 386,933 shares (30-day average 551,658).
Data as of November 13, 2026.
13-Nov-2026
Kardigan, Inc. (KARD) Gets a Buy from Leerink Partners
TipRanks (Fri, 13-Nov 9:37 AM ET)
Kardigan, Inc. (KARD) Receives a Buy from TD Cowen
TipRanks (Fri, 13-Nov 9:06 AM ET)
TipRanks (Thu, 12-Nov 10:30 AM ET)
Kardigan Q3 GAAP EPS of -$0.64 beats by $0.43
Seeking Alpha News (Thu, 12-Nov 9:49 AM ET)
Kardigan Reports Third Quarter 2026 Financial Results and Recent Business Updates
Business Wire (Thu, 12-Nov 7:00 AM ET)
Kardigan to Participate in the Jefferies Global Healthcare Conference
Business Wire (Wed, 11-Nov 7:00 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Tue, 10-Nov 7:50 AM ET)
Cantor Fitzgerald Remains a Buy on Kardigan, Inc. (KARD)
TipRanks (Mon, 9-Nov 9:25 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Aquestive Therapeutics (AQST), Kardigan, Inc. (KARD)
TipRanks (Mon, 9-Nov 7:50 AM ET)
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Kardigan trades on the NASDAQ stock market under the symbol KARD.
As of November 13, 2026, KARD stock price declined to $13.82 with 386,933 million shares trading.
KARD has a beta of -0.69, meaning it tends to be less sensitive to market movements. KARD has a correlation of 0.02 to the broad based SPY ETF.
KARD has a market cap of $1.29 billion. This is considered a Small Cap stock.
The top ETF exchange traded funds that KARD belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.
KARD support price is $13.26 and resistance is $14.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KARD shares will trade within this expected range on the day.
